UnknownNot Applicable

Dermatologic Tacrolimus Ointment on Eyelids in the Treatment of Refractory Vernal Keratoconjunctivitis and Atopic Keratoconjunctivitis

Taiwan10 participantsStarted 2018-06-01

Plain-language summary

To evaluate the therapeutic effects of dermatologic tacrolimus ointment on eyelids to treat refractory vernal keratoconjunctivitis and atopic keratoconjunctivitis.

Who can participate

Age range7 Years – 19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * all patients diagnosed as severe vernal keratoconjunctivitis or atopic Keratoconjunctivitis and received topical dermatological tacrolimus ointment on upper eyelids between January, 2016 and January, 2018 at National Taiwan University Hospital. Exclusion Criteria: * none

What they're measuring

serial external ocular photography and full chart records of patients who diagnosed as patients diagnosed as severe vernal keratoconjunctivitis and atopic keratoconjunctivitis refractory to steroid treatment

Timeframe: 2018/6/1-2019/5/31

Trial details

NCT IDNCT03557203

SponsorNational Taiwan University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-05-31

Contact for this trial

I-Jong Wang, professor

886-2-23123456 ijong@ntu.edu.tw

View on ClinicalTrials.gov More Vernal Keratoconjunctivitis trials